TrialBMJ open2024

Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial.

William King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.